Isaura de Oliveira Carrijo, L. A. Ugrinovich, P. Simioni
{"title":"Primary sclerosing cholangitis associated with inflammatory bowel disease","authors":"Isaura de Oliveira Carrijo, L. A. Ugrinovich, P. Simioni","doi":"10.5455/IM.48059","DOIUrl":null,"url":null,"abstract":"Primary sclerosing cholangitis (PSC) is a rare chronic cholestatic liver disease characterized by inflammation of the intra and extrahepatic bile ducts with progression to cirrhosis. To the present, the etiology of PSC is not known. Although it is possible to establish a correlation with a genetic predisposition, it is an autoimmune disease, associated with ulcerative colitis and Crohn's disease. There is no proven medical treatment that prolongs survival in PSC, being liver transplantation the only curative treatment, with recurrence of 20% of cases within the first five years after transplantation.","PeriodicalId":93574,"journal":{"name":"International medicine (Antioch, Turkey)","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International medicine (Antioch, Turkey)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5455/IM.48059","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
Primary sclerosing cholangitis (PSC) is a rare chronic cholestatic liver disease characterized by inflammation of the intra and extrahepatic bile ducts with progression to cirrhosis. To the present, the etiology of PSC is not known. Although it is possible to establish a correlation with a genetic predisposition, it is an autoimmune disease, associated with ulcerative colitis and Crohn's disease. There is no proven medical treatment that prolongs survival in PSC, being liver transplantation the only curative treatment, with recurrence of 20% of cases within the first five years after transplantation.